A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.

Affinia Therapeutics, a US-based gene therapy developer based on research at Harvard University, has filed to raise up to $100m in an initial public offering on the Nasdaq Global Market that would represent an exit for chemical producer Lonza, internet and technology group Alphabet and care provider Mass General Brigham. The company had raised $170m as of a $110m series B round in May 2021 featuring Lonza and corporate venturing units GV and Mass General Brigham Ventures. Trifacta, a US-based data management software producer based on research at Stanford University and University of California, Berkeley, has agreed to a $400m all-cash acquisition by analytics automation technology provider Alteryx. The deal allowed corporates Telstra, NTT Docomo, BMW, Google, Infosys, ABN Amro, Deutsche Börse, Ericsson and New York Life to exit. Trifacta had raised a total of $224m as of a $100m funding round in 2019 valuing it below $1bn. Replica Analytics, a Canada-based provider of synthetic datasets for sensitive artificial intelligence projects, has agreed to an acquisition by healthcare analytics company Aetion, providing an exit to Facit, the seed-stage commercialisation unit allied to Ontario Institute for Cancer Research. Financial terms were not disclosed. Facit had participated in a $1m pre-seed round for Replica Analytics in September 2020. Warden Bio, a US-based developer of adeno-associated virus-mediated gene therapies for glycogen storage disorders spun out of Duke University, has agreed to an acquisition of undisclosed size by gene therapy producer Kriya Therapeutics. Warden Bio does not appear to have disclosed any equity funding. – Additional reporting by Robert Lavine

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).